BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24559478)

  • 21. Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo.
    Borrás T; Gabelt BT; Klintworth GK; Peterson JC; Kaufman PL
    J Gene Med; 2001; 3(5):437-49. PubMed ID: 11601757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
    Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B
    Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility.
    Kiland JA; Gabelt BT; Kaufman PL
    Exp Eye Res; 2004 Mar; 78(3):639-51. PubMed ID: 15106944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in non-human primates.
    Matet A; Kostic C; Bemelmans AP; Moulin A; Rosolen SG; Martin S; Mavilio F; Amirjanians V; Stieger K; Lorenz B; Behar-Cohen F; Arsenijevic Y
    Transl Res; 2017 Oct; 188():40-57.e4. PubMed ID: 28754419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway.
    Sagara T; Gaton DD; Lindsey JD; Gabelt BT; Kaufman PL; Weinreb RN
    Arch Ophthalmol; 1999 Jun; 117(6):794-801. PubMed ID: 10369592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles.
    Dissen GA; Lomniczi A; Neff TL; Hobbs TR; Kohama SG; Kroenke CD; Galimi F; Ojeda SR
    Methods; 2009 Sep; 49(1):70-7. PubMed ID: 19559089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in glaucoma treatment and management: gene therapy.
    Borrás T
    Invest Ophthalmol Vis Sci; 2012 May; 53(5):2506-10. PubMed ID: 22562852
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of topical ethacrynic acid ointment vs timolol on intraocular pressure in glaucomatous monkey eyes.
    Wang RF; Podos SM; Serle JB; Lee PY; Neufeld AH; Deschenes R
    Arch Ophthalmol; 1994 Mar; 112(3):390-4. PubMed ID: 8129666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and regulation of the messenger for a putative bovine endometrial 9-keto-prostaglandin E(2) reductase: effect of oxytocin and interferon-tau.
    Asselin E; Fortier MA
    Biol Reprod; 2000 Jan; 62(1):125-31. PubMed ID: 10611076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentiviral mediated gene delivery to the anterior chamber of rodent eyes.
    Challa P; Luna C; Liton PB; Chamblin B; Wakefield J; Ramabhadran R; Epstein DL; Gonzalez P
    Mol Vis; 2005 Jun; 11():425-30. PubMed ID: 15988411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of key prostaglandin synthases in equine endometrium during late diestrus and early pregnancy.
    Boerboom D; Brown KA; Vaillancourt D; Poitras P; Goff AK; Watanabe K; Doré M; Sirois J
    Biol Reprod; 2004 Feb; 70(2):391-9. PubMed ID: 14561653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Lentivirus-Mediated C3 Expression on Trabecular Meshwork Cells and Intraocular Pressure.
    Tan J; Fan N; Wang N; Feng B; Yang M; Liu G; Wang Y; Zhu X; Kaufman PL; Pang IH; Liu X
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4937-4944. PubMed ID: 30326062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durable, safe, multi-gene lentiviral vector expression in feline trabecular meshwork.
    Khare PD; Loewen N; Teo W; Barraza RA; Saenz DT; Johnson DH; Poeschla EM
    Mol Ther; 2008 Jan; 16(1):97-106. PubMed ID: 17912236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing.
    Prasanna G; Ferrara L; Adams C; Ehara T; Li B; Yang L; Xiang C; Ng CTH; Kim S; Towler C; Topley T; McAllister C; Ghosh M; Newton R; Stacy R; Rice DS; Mogi M
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1704-1716. PubMed ID: 29610853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. sCD44 overexpression increases intraocular pressure and aqueous outflow resistance.
    Giovingo M; Nolan M; McCarty R; Pang IH; Clark AF; Beverley RM; Schwartz S; Stamer WD; Walker L; Grybauskas A; Skuran K; Kuprys PV; Yue BY; Knepper PA
    Mol Vis; 2013; 19():2151-64. PubMed ID: 24194636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the prostaglandin F synthase activity of human and bovine aldo-keto reductases: AKR1A1s complement AKR1B1s as potent PGF synthases.
    Lacroix Pépin N; Chapdelaine P; Fortier MA
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():124-32. PubMed ID: 23747692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning and spatiotemporal expression of prostaglandin F synthase and microsomal prostaglandin E synthase-1 in porcine endometrium.
    Waclawik A; Rivero-Muller A; Blitek A; Kaczmarek MM; Brokken LJ; Watanabe K; Rahman NA; Ziecik AJ
    Endocrinology; 2006 Jan; 147(1):210-21. PubMed ID: 16223862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis and degradation of canine placental prostaglandins: prepartum changes in expression and function of prostaglandin F2α-synthase (PGFS, AKR1C3) and 15-hydroxyprostaglandin dehydrogenase (HPGD).
    Gram A; Büchler U; Boos A; Hoffmann B; Kowalewski MP
    Biol Reprod; 2013 Jul; 89(1):2. PubMed ID: 23677986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy.
    Borrás T; Buie LK; Spiga MG
    Gene Ther; 2016 May; 23(5):438-49. PubMed ID: 26855269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.